5.19
-0.08 (-1.52%)
-0.08 (-1.52%)
Upgrade to Real-Time
Regular Market
Low
3.91
High
15.00
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gamida Cell Ltd | GMDA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.08 | -1.52% | 5.19 | 15:55:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.22 | 5.15 | 5.44 | 5.27 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.16 | 5.19 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,048 | 331,997 | $ 5.30 | $ 1,759,397 | - | 3.91 - 15.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:55:11 | 100 | $ 5.19 | USD |
Period:
Draw Mode:
Gamida Cell Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 307.25M | 59.20M | 49.46M | $ - | $ - | -1.66 | -3.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Gamida Cell News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GMDA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.82 | 5.84 | 4.80 | 5.18 | 1,074,629 | -0.63 | -10.82% |
| 1 Month | 6.33 | 6.41 | 4.80 | 5.41 | 411,926 | -1.14 | -18.01% |
| 3 Months | 6.77 | 7.09 | 4.80 | 5.97 | 323,838 | -1.58 | -23.34% |
| 6 Months | 8.20 | 15.00 | 4.80 | 9.01 | 577,301 | -3.01 | -36.71% |
| 1 Year | 3.97 | 15.00 | 3.91 | 8.54 | 528,574 | 1.22 | 30.73% |
| 3 Years | 8.30 | 15.41 | 2.60 | 7.90 | 244,973 | -3.11 | -37.47% |
| 5 Years | 8.30 | 15.41 | 2.60 | 7.90 | 244,973 | -3.11 | -37.47% |
Gamida Cell Description
| Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the life-saving benefits of hematopoietic stem cell transplant. It is also developing GDA-201 which is innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma. It is developing a diverse pipeline of cell therapies using its proprietary NAM technology that has the potential to bring life-saving treatment options to patients. |
